GILD

Gilead Sciences Inc. Earnings

$109.95

Earnings Summary

Revenue	$7569Mn
Net Profits	$1783Mn
Net Profit Margins	23.56%
PE Ratio	289.55

Highlights

Revenue:

Gilead Sciences Inc.’s revenue jumped 6.38% since last year same period to $7569Mn in the Q4 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated 0.32% jump in its revenue since last 3-months.

Net Profits:

Gilead Sciences Inc.’s net profit jumped 24.77% since last year same period to $1783Mn in the Q4 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated 42.3% jump in its net profits since last 3-months.

Net Profit Margins:

Gilead Sciences Inc.’s net profit margin jumped 17.29% since last year same period to 23.56% in the Q4 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated 41.85% jump in its net profit margins since last 3-months.

PE Ratio:

Gilead Sciences Inc.’s price-to-earnings ratio after this Q4 2024 earnings stands at 289.55.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Gilead Sciences Inc. post its latest quarter earnings

EPS Estimate Current Quarter	1.7
EPS Estimate Current Year	1.7

Highlights

EPS Estimate Current Quarter:

Gilead Sciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.7 - a 9.71% jump from last quarter’s estimates.

EPS Estimate Current Year:

Gilead Sciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.7.

Key Ratios

Key ratios of the Gilead Sciences Inc. post its Q4 2024 earnings

Earning Per Share (EPS)	1.9
Return on Assets (ROA)	0.11
Return on Equity (ROE)	0.02
Dividend Per Share (DPS)	0.77

Highlights

Earning Per Share (EPS):

Gilead Sciences Inc.’s earning per share (EPS) jumped 10.47% since last year same period to 1.9 in the Q4 2024. This indicates that the Gilead Sciences Inc. has generated 10.47% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Gilead Sciences Inc.’s return on assets (ROA) stands at 0.11.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Gilead Sciences Inc.’s return on equity (ROE) stands at 0.02.

Dividend Per Share (DPS):

Gilead Sciences Inc. declared 0.77 dividend per share during the earnings announcement for Q4 2024.